Commentary on “Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813”

類似資料

• Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813
  著者:: Chang, Susan, 等
  出版事項: (2017)
• ATCT-12 RESULTS OF NRG ONCOLOGY/RTOG 9813- A PHASE III RANDOMIZED STUDY OF RADIATION THERAPY (RT) AND TEMOZOLOMIDE (TMZ) VERSUS RT AND NITROSOUREA (NU) THERAPY FOR ANAPLASTIC ASTROCYTOMA (AA)
  著者:: Chang, Susan, 等
  出版事項: (2015)
• Reply to letter on results of NRG Oncology RTOG 9813
  著者:: Chang, Susan M., 等
  出版事項: (2017)
• Phase 2 Study of Radiation Therapy Plus Low Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420
  著者:: Lieberman, Frank S, 等
  出版事項: (2018)
• Psychological Treatment for Patients Receiving Radiation: Results of NRG Oncology/RTOG 0841
  著者:: Small, William, 等
  出版事項: (2021)